Cargando…

HLA class I-drug-T-cell receptor interactions in SJS/TEN

Detalles Bibliográficos
Autores principales:	Rive, Craig, Pavlos, Rebecca, Ostrov, David, Plasencia, Pablo, Hung, Shien-Iu, Chung, WenHung, Peters, Bjoern, Buus, Soren, Mallal, Simon, Phillips, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128191/ http://dx.doi.org/10.1186/2045-7022-4-S3-P2

Ejemplares similares

Updates in SJS/TEN: collaboration, innovation, and community
por: Marks, Madeline E., et al.
Publicado: (2023)

Role of blister fluid soluble HLA-E In SJS/TEN
por: Escamochero, Salvador, et al.
Publicado: (2014)

Susceptibility Genes and HLA for Cold Medicine-Related SJS/TEN with SOC
por: Ueta, Mayumi
Publicado: (2022)

Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles
por: Pavlos, Rebecca, et al.
Publicado: (2017)

Pediatric SJS-TEN: Where are we now?
por: Ramien, Michele, et al.
Publicado: (2020)

Causative Drugs and Clinical Outcome in Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and SJS-TEN Overlap in Children
por: Sethuraman, Gomathy, et al.
Publicado: (2012)

Sepsis assessment in SJS/TEN: an important point overlooked?()()
por: Khurana, Ananta, et al.
Publicado: (2019)

Cost-Effectiveness Analysis of HLA-B*5801 Testing in Preventing Allopurinol-Induced SJS/TEN in Thai Population
por: Saokaew, Surasak, et al.
Publicado: (2014)

HLA Allele Frequencies in 5802 Koreans: Varied Allele Types Associated with SJS/TEN According to Culprit Drugs
por: Park, Hye Jung, et al.
Publicado: (2016)

Acyclovir Has Low but Detectable Influence on HLA-B*57:01 Specificity without Inducing Hypersensitivity
por: Metushi, Imir G., et al.
Publicado: (2015)

Sepsis assessment in SJS/TEN: an important point overlooked? – Reply()()
por: Wambier, Carlos Gustavo, et al.
Publicado: (2019)

Findings by an International Collaboration on SJS/TEN With Severe Ocular Complications
por: Ueta, Mayumi
Publicado: (2021)

Amifostine Before Radiotherapy: A Rare Cause of SJS-TEN Overlap
por: Sengupta, Sujata
Publicado: (2015)

The Correlation of Neutrophil–Lymphocyte Ratio and Eosinophil Count with SCORTEN in SJS/TEN
por: Primisawitri, Pratiwi Prasetya, et al.
Publicado: (2022)

55 Risk of Sepsis and Mortality in SJS and TENS Patients Treated with Corticosteroids
por: Everett, Catherine, et al.
Publicado: (2023)

Stevens–Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN): Immunologic Reactions
por: Zimmerman, Danielle, et al.
Publicado: (2019)

510 Outcomes for Patients with SJS/TENS with Diabetes Compared to other Comorbid Conditions
por: Chandran, Keshav, et al.
Publicado: (2023)

293 Risk of Clostridium Difficile Enterocolitis in SJS/TENS Patients Treated with Antibiotics
por: Skidmore, Savannah, et al.
Publicado: (2023)

Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS–TEN overlap and potential drug–drug interactions during treatment: a retrospective analysis at an Indonesian referral hospital
por: Abdulah, Rizky, et al.
Publicado: (2017)

Stevens–Johnson syndrome–toxic epidermal necrolysis (SJS–TEN) overlap associated with carbamazepine use
por: Suresh Kumar, P.N., et al.
Publicado: (2005)

Stevens Johnson Syndrome: Past, Present, and Future Directions Gynecologic Manifestations and Management in SJS/TEN
por: DenAdel, Michelle A., et al.
Publicado: (2022)

Abacavir-Reactive Memory T Cells Are Present in Drug Naïve Individuals
por: Lucas, Andrew, et al.
Publicado: (2015)

Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile
por: Chihab, Leila Y., et al.
Publicado: (2022)

717 Management of Gynecologic Involvement in Stevens-Johnson Syndrome (SJS)/ Toxic Epidermal Necrolysis Syndrome (TENS)
por: Knapp, Rachel, et al.
Publicado: (2023)

SJS/TEN immune-related dermatologic reaction secondary to immune checkpoint inhibitor pembrolizumab in skin of color
por: Pierre, A.B., et al.
Publicado: (2023)

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN): Could Retinoids Play a Causative Role?
por: Mawson, Anthony R., et al.
Publicado: (2015)

Increased Predisposition of SJS TEN in COVID-19 Patients, Presenting as Post COVID Complication: Report of Two Cases
por: Aulakh, Shayna, et al.
Publicado: (2022)

Stevens Johnson syndrome after carbamazepine and SJS/TEN overlap syndrome after amoxicillin: case reports and a review
por: Romańska-Gocka, Krystyna, et al.
Publicado: (2010)

Allopurinol-Induced Stevens–Johnson Syndrome (SJS)
por: Anis, Takla R, et al.
Publicado: (2023)

Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan
por: Nielsen, Morten, et al.
Publicado: (2008)

Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction
por: Wendorff, Mareike, et al.
Publicado: (2020)

A Case Study of Stevens–Johnson Syndrome-Toxic Epidermal Necrolysis (SJS-TEN) Overlap in Mycoplasma pneumoniae-Associated Tracheobronchitis
por: Sah, Ranjit, et al.
Publicado: (2019)

HLA class I supertypes: a revised and updated classification
por: Sidney, John, et al.
Publicado: (2008)

Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors
por: Sooda, Anuradha, et al.
Publicado: (2022)

Quality of Life of Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) and Stevens-Johnson Syndrome (SJS) and/or Toxic Epidermal Necrolysis (TEN) Patients
por: Perwitasari, Dyah Aryani, et al.
Publicado: (2021)

IL-15/IL-15Rα in SJS/TEN: Relevant Expression of IL15 and IL15RA in Affected Skin
por: Bellón, Teresa, et al.
Publicado: (2022)

Correlations between histopathologic findings, serum biomarker levels, and clinical outcomes in Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)
por: Chuenwipasakul, Donlaporn, et al.
Publicado: (2023)

Immunogenicity of HLA Class I and II Double Restricted Influenza A-Derived Peptides
por: Pedersen, Sara Ram, et al.
Publicado: (2016)

Footprints of antigen processing boost MHC class II natural ligand predictions
por: Barra, Carolina, et al.
Publicado: (2018)

Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501
por: Røder, Gustav, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_9kbrg478g26j63t3rtm5t5u19o